Li Zheng, Hogan Karen A, Cai Christine, Rieth Susan
National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA.
Environ Health Perspect. 2016 Jun;124(6):703-12. doi: 10.1289/ehp.1509730. Epub 2015 Nov 3.
In support of the Integrated Risk Information System (IRIS), the U.S. Environmental Protection Agency (EPA) has evaluated the human health hazards of biphenyl exposure.
We review key findings and scientific issues regarding expected human health effects of biphenyl.
Scientific literature from 1926 through September 2012 was critically evaluated to identify potential human health hazards associated with biphenyl exposure. Key issues related to the carcinogenicity and noncancer health hazards of biphenyl were examined based on evidence from experimental animal bioassays and mechanistic studies.
Systematic consideration of experimental animal studies of oral biphenyl exposure took into account the variety of study designs (e.g., study sizes, exposure levels, and exposure durations) to reconcile differing reported results. The available mechanistic and toxicokinetic evidence supports the hypothesis that male rat urinary bladder tumors arise through urinary bladder calculi formation but is insufficient to hypothesize a mode of action for liver tumors in female mice. Biphenyl and its metabolites may induce genetic damage, but a role for genotoxicity in biphenyl-induced carcinogenicity has not been established.
The available health effects data for biphenyl provides suggestive evidence for carcinogenicity in humans, based on increased incidences of male rat urinary bladder tumors at high exposure levels and on female mouse liver tumors. Kidney toxicity is also a potential human health hazard of biphenyl exposure.
Li Z, Hogan KA, Cai C, Rieth S. 2016. Human health effects of biphenyl: key findings and scientific issues. Environ Health Perspect 124:703-712; http://dx.doi.org/10.1289/ehp.1509730.
为支持综合风险信息系统(IRIS),美国环境保护局(EPA)评估了联苯暴露对人类健康的危害。
我们回顾关于联苯对人类健康预期影响的关键发现和科学问题。
对1926年至2012年9月的科学文献进行严格评估,以确定与联苯暴露相关的潜在人类健康危害。基于实验动物生物测定和机制研究的证据,研究了与联苯致癌性和非癌症健康危害相关的关键问题。
对口服联苯暴露的实验动物研究进行系统考量时,考虑了各种研究设计(如研究规模、暴露水平和暴露持续时间),以协调不同的报告结果。现有的机制和毒代动力学证据支持这样的假设,即雄性大鼠膀胱肿瘤是通过膀胱结石形成产生的,但不足以假设雌性小鼠肝脏肿瘤的作用模式。联苯及其代谢产物可能会诱导遗传损伤,但尚未确定遗传毒性在联苯诱导的致癌性中的作用。
基于高暴露水平下雄性大鼠膀胱肿瘤发病率增加以及雌性小鼠肝脏肿瘤,联苯现有的健康影响数据为其对人类的致癌性提供了提示性证据。肾脏毒性也是联苯暴露对人类健康的潜在危害。
Li Z, Hogan KA, Cai C, Rieth S. 2016. 联苯对人类健康的影响:关键发现和科学问题。环境健康展望124:703 - 712;http://dx.doi.org/10.1289/ehp.1509730。